Challenges and Opportunities for Respiratory Syncytial Virus Vaccines by Larry J. AndersonChallenges and Opportunities for Respiratory Syncytial Virus Vaccines by Larry J. Anderson

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines

EditorLarry J. Anderson, Barney S. Graham

Hardcover | January 7, 2014

Pricing and Purchase Info

$250.22 online 
$285.95 list price save 12%
Earn 1251 plum® points

In stock online

Ships free on orders over $25

Not available in stores


Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine.
Title:Challenges and Opportunities for Respiratory Syncytial Virus VaccinesFormat:HardcoverDimensions:350 pagesPublished:January 7, 2014Publisher:Springer Berlin HeidelbergLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:364238918X

ISBN - 13:9783642389184

Look for similar items by category:


Table of Contents

Part I  Virology,  Pathogenesis, and Clinical and Epidemiological Features of Disease Respiratory Syncytial Virus: Virology, Reverse Genetics, and Pathogenesis of DiseasePeter L. Collins, Rachel Fearns, and Barney S. Graham Clinical and Epidemiologic Features of Respiratory Syncytial VirusCaroline B. Hall, Eric A. F. Simoes, and Larry J. Anderson Influence of Respiratory Syncytial Virus Strain Differences on Pathogenesis and ImmunityJosé A. Melero and Martin L. Moore Structure and Function of Respiratory Syncytial Virus Surface GlycoproteinsJason S. McLellan, William C. Ray and Mark E. Peeples Respiratory Syncytial Virus and Reactive Airway DiseaseMatthew T. Lotz, Martin L. Moore, and R. Stokes Peebles, Jr.  Part II  Host Response to Infection and Genetics of Disease Human Genetics and Respiratory Syncytial Virus Disease: Current Findings and Future ApproachesEun Hwa Choi, Hoan Jong Lee, and Stephen J. Chanock Innate Immune Responses to Respiratory Syncytial Virus Infection Sumanta Mukherjee and Nicholas W. Lukacs The Adaptive Immune Response to Respiratory Syncytial VirusSteven. M. Varga and Thomas J. Braciale Respiratory Syncytial Virus Mechanisms to Interfere with Type 1 InterferonsSailen Barik Host Gene Expression and Respiratory Syncytial Virus InfectionRalph A. Tripp, Asuncion Mejias, and Octavio Ramilo Consequences of Immature and Senescent Immune Responses for Infection with Respiratory Syncytial VirusAllison M.W. Malloy, Ann R. Falsey, and Tracy J. Ruckwardt Part III  Vaccine Platforms and Treatment Options Respiratory Syncytial Virus Disease:  Prevention and Treatment Helen Y.  Chu and Janet A. Englund Live-Attenuated Respiratory Syncytial Virus VaccinesRuth A. Karron, Ursula J. Buchholz, and Peter L. Collins Subunit and Virus-Like Particle Vaccine Approaches for Respiratory Syncytial VirusTrudy G. Morrison and Edward E. Walsh Gene-Based Vaccine Approaches for Respiratory Syncytial VirusRebecca J. Loomis and Philip R. JohnsonPart IV  Animal and Tissue Culture Models of InfectionBovine Model of Respiratory Syncytial Virus InfectionGeraldine Taylor The Cotton Rat S. hispidus Model of Respiratory Syncytial Virus InfectionMarina S. Boukhvalova and Jorge C.G. Blanco The Mouse Model of Respiratory Syncytial Virus DiseasePeter J. Openshaw Human Airway Epithelial Cell Cultures for Modeling Respiratory Syncytial Virus InfectionRaymond J. Pickles Part V  Conclusions Challenges and Opportunities for Respiratory Syncytial Virus VaccinesBarney S. Graham and Larry J. Anderson